Examkin

Soru

Zorluk: OrtaGynecologic Infections

Presenting to a community health clinic, a 24-year-old female college student complains of a bilateral lower pelvic ache and abnormal vaginal spotting that began four days ago. She denies nausea, vomiting, or recent fever. Her medical history is unremarkable, and she uses a hormonal etonogestrel subdermal implant for contraception. She reports having a new male partner for the past month and inconsistent barrier protection use. Vital signs reveal a temperature of 37.1°C (98.8°F), blood pressure of 118/76 mm Hg, and heart rate of 78/min. Abdominal palpation elicits mild discomfort in the bilateral lower quadrants without guarding or rebound. During the pelvic examination, a mucopurulent discharge is noted at the cervical os, and the cervix bleeds easily upon swabbing. Bimanual examination demonstrates pronounced tenderness upon cervical motion as well as bilateral adnexal tenderness. No adnexal masses are palpable. A rapid point-of-care pregnancy test is negative. Which of the following is the most appropriate next step in the management of this patient?

  1. Empiric outpatient therapy with intramuscular ceftriaxone, oral doxycycline, and oral metronidazoleCevap
  2. B
    Empiric outpatient therapy with intramuscular ceftriaxone and a single dose of oral azithromycin
  3. C
    Hospital admission for intravenous cefoxitin and oral doxycycline
  4. D
    Empiric outpatient therapy with oral metronidazole monotherapy
  5. E
    Deferral of antimicrobial therapy pending nucleic acid amplification test results

Cevap

Empiric outpatient therapy with intramuscular ceftriaxone, oral doxycycline, and oral metronidazole
The patient's clinical presentation of lower abdominal pain accompanied by pronounced cervical motion and adnexal tenderness establishes a presumptive diagnosis of acute pelvic inflammatory disease (PID). Because delaying treatment can lead to severe long-term complications such as tubal factor infertility and ectopic pregnancy, empiric antimicrobial therapy must be initiated immediately. Current guidelines for mild-to-moderate outpatient PID recommend a single dose of intramuscular ceftriaxone (for gonococcal coverage) combined with a 14-day course of oral doxycycline (for chlamydial coverage) and oral metronidazole (for anaerobic coverage). Inpatient admission is not indicated as she is hemodynamically stable, non-pregnant, afebrile, and lacks evidence of a tubo-ovarian abscess.

Adım Adım Çözüm

1
Identify the clinical syndrome based on the patient's presentation and physical examination findings.
The patient presents with lower pelvic pain, mucopurulent cervical discharge, cervical friability, cervical motion tenderness, and adnexal tenderness.
These findings satisfy the minimum clinical criteria for a presumptive diagnosis of acute pelvic inflammatory disease (PID).
2
Determine the appropriate setting of care for the patient (inpatient vs. outpatient).
Outpatient management is appropriate.
The patient is afebrile, hemodynamically stable, not pregnant, tolerating oral intake, and lacks clinical evidence of a tubo-ovarian abscess or surgical emergency.
3
Select the most appropriate evidence-based empiric antimicrobial regimen for the determined setting.
Intramuscular ceftriaxone combined with a 14-day course of oral doxycycline and oral metronidazole is selected.
This regimen provides comprehensive coverage against Neisseria gonorrhoeae, Chlamydia trachomatis, and anaerobic vaginal flora, strictly adhering to current CDC guidelines for outpatient PID management.

Anahtar Kavram

Diagnosis and outpatient management of uncomplicated pelvic inflammatory disease (PID) using comprehensive empiric antimicrobial therapy.
Bu soruyu puanla

Konular

Gynecologic Infections

Bu konudan daha fazla soru